MEP of the week

Lobby organisation

European Confederation of Pharmaceutical Entrepreneurs

Business / industry · Health & pharma · HQ: Belgium · Transparency Register entry

As of 9 September 2026, European Confederation of Pharmaceutical Entrepreneurs appears in 50 declared MEP meetings (31 different MEPs), most often with European People's Party.

50
declared meetings
with current MEPs
31
MEPs met
€800,000/yr
declared lobbying spend
self-reported to the register
4.5
lobbyists
full time equivalent

In their own words

“The European Confederation for Pharmaceutical Entrepreneurs (EUCOPE) is the voice of small to medium-sized innovative companies in the fields of pharmaceuticals, biotechnologies and medical devices. Via its member associations such as the German Pharmaceutical Industry Association (BPI), the British Ethical Medicines Industry Group (EMIG), France Biotech and the Swedish Association lif, EUCOPE represents over 2600 member companies. Corporate members include…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 50 declared meetings, by the meeting MEP's political group.

European People's Party2856%
Socialists & Democrats918%
European Conservatives & Reformists48%
Renew Europe48%
Greens/EFA36%
Patriots for Europe12%
The Left12%

Meetings by year

Declared meetings per calendar year, 2020–2026. Bar length is relative to its busiest year (17 in 2025).

2020
1
2021
1
2022
2
2023
6
2024
10
2025
17
2026
13

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tomislav Sokol
7 meetings · EPP
Tiemo Wölken
3 meetings · S&D
Tilly Metz
3 meetings · Greens/EFA
Oliver Schenk
3 meetings · EPP

The 15 most recent declared meetings

DateMEPSubject
4 Sep 2026Marie-Sophie LanigEU Health Policy
20 Jul 2026Angelika NieblerEU Pharma Policies
29 Apr 2026Nikos PapandreouRare diseases
28 Apr 2026Aurelijus VerygaStrengthening EU Action on Rare Diseases and Life Sciences Competitiveness
28 Apr 2026Tomislav SokolHealth Policy
28 Apr 2026Tilly MetzRare diseases
28 Apr 2026Radan KanevMedicines for rare diseases
28 Apr 2026Michalis HadjipantelaBiotech Act
28 Apr 2026Vytenis Povilas AndriukaitisBiotech Act
22 Apr 2026Wouter BekeBiotech Act I
14 Apr 2026Tiemo WölkenHTA
25 Mar 2026Oliver SchenkMedical device regulation
3 Mar 2026Aurelijus VerygaExchange of Views with the European Confederation of Pharmaceutical Entrepreneurs on the UCPM and Health Preparedness
6 Nov 2025András Tivadar KuljaGPL
2 Oct 2025Ingeborg ter LaakOrphan Medicines

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.